Clinical Trial Update: Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing tigecycline with imipenem/cilastatin for hospital-acquired pneumonia was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia

Drugs mentioned

• Imipenem/Cilastatin (imipenem/cilastatin)
• Tigecycline (tigecycline)

Snippet

Sponsor: Pfizer | Conditions: Pneumonia, Bacterial | Phase 2 | Status: TERMINATED | Results posted: 2012-07-10